Refund  Policy – PsychCarts

At PsychCarts, we strive to ensure customer satisfaction with every purchase. Our refund and return policy lasts 30 days from the date of purchase. If more than 30 days have passed, we regret that we cannot offer a full refund or exchange.

Return Eligibility

To qualify for a return, your item must:
✔ Be unused and in its original condition
✔ Be in the original packaging

Refund Process

Once we receive and inspect your return, we will notify you via email regarding the approval or rejection of your refund.

 If  approved, your refund will be processed and credited to your original payment method within a specified period.

If you haven’t received your refund yet:
Check your bank account again
Contact your credit card provider – It may take time before the refund appears Contact your bank – Processing times vary Still no refund? Contact us at sales@psychcarts.com

 

CORREA, BERGMAN MEET WITH VA SECY. COLLINS, DISCUSS PSYCHEDELIC-ASSISTED THERAPIES RESEARCH AND ACCESS FOR VETERANS

WASHINGTON — Yesterday, Representatives Lou Correa (CA-46) and General Jack Bergman (MI-01), Co-Chairs of the [...]

Can Psychedelics Break Through in Depression? Recent Readouts Leave Investors Wanting More

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks [...]

Support for psychedelic treatments means full steam ahead at Compass, despite stock drop

Though UK-based pharmaceutical company Compass Pathways reached its primary endpoint from its June 23 Phase [...]

Texas is the latest state to embrace psychedelic therapy research for mental health treatment

Marine Corps veteran Ryan Roberts participates in a mock therapy session in a psilocybin dosing [...]

New Zealand Approved Psychedelic Therapy. He’s the Only Doctor Who Can Do It.

Dr. Cameron Lacey has spent years studying how psychedelics might help treat depression and other [...]

RFK Jr. is bringing psychedelics to the Republican Party

Then in August, the Food and Drug Administration rejected drugmaker Lykos Therapeutics’ application to offer [...]